 Laura Hurley
Concepts (208)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Physicians, Primary Care | 16 | 2024 | 229 | 4.070 |
Why?
| | Vaccination | 40 | 2025 | 1346 | 3.420 |
Why?
| | Practice Patterns, Physicians' | 25 | 2024 | 1258 | 2.590 |
Why?
| | Attitude of Health Personnel | 28 | 2024 | 1093 | 2.520 |
Why?
| | Vaccines | 14 | 2025 | 393 | 2.220 |
Why?
| | Health Knowledge, Attitudes, Practice | 13 | 2025 | 1275 | 2.200 |
Why?
| | Influenza Vaccines | 15 | 2024 | 536 | 2.060 |
Why?
| | Herpes Zoster Vaccine | 7 | 2022 | 162 | 1.990 |
Why?
| | Pneumococcal Vaccines | 6 | 2021 | 139 | 1.950 |
Why?
| | Physicians, Family | 11 | 2021 | 206 | 1.610 |
Why?
| | Influenza, Human | 11 | 2023 | 601 | 1.450 |
Why?
| | Herpes Zoster | 4 | 2022 | 317 | 1.400 |
Why?
| | Health Care Surveys | 13 | 2021 | 555 | 1.260 |
Why?
| | Immunization | 8 | 2021 | 412 | 1.130 |
Why?
| | Papillomavirus Vaccines | 8 | 2021 | 229 | 1.110 |
Why?
| | Surveys and Questionnaires | 23 | 2025 | 5362 | 0.960 |
Why?
| | Immunization, Secondary | 1 | 2025 | 87 | 0.940 |
Why?
| | Immunization Schedule | 9 | 2021 | 198 | 0.930 |
Why?
| | Papillomavirus Infections | 5 | 2021 | 290 | 0.930 |
Why?
| | Primary Health Care | 10 | 2024 | 1668 | 0.910 |
Why?
| | Physicians | 10 | 2022 | 858 | 0.900 |
Why?
| | Guideline Adherence | 4 | 2024 | 521 | 0.840 |
Why?
| | Vaccines, Synthetic | 2 | 2022 | 126 | 0.780 |
Why?
| | Diphtheria-Tetanus-acellular Pertussis Vaccines | 4 | 2019 | 91 | 0.770 |
Why?
| | Respiratory Function Tests | 1 | 2024 | 580 | 0.770 |
Why?
| | Pediatricians | 7 | 2022 | 130 | 0.760 |
Why?
| | Internal Medicine | 5 | 2014 | 246 | 0.750 |
Why?
| | General Practitioners | 2 | 2021 | 27 | 0.740 |
Why?
| | Insurance, Health, Reimbursement | 4 | 2018 | 95 | 0.700 |
Why?
| | Reminder Systems | 3 | 2018 | 174 | 0.680 |
Why?
| | Adult | 42 | 2025 | 35299 | 0.670 |
Why?
| | Vaccination Refusal | 5 | 2021 | 69 | 0.670 |
Why?
| | Asthma | 5 | 2024 | 2213 | 0.630 |
Why?
| | Patient Protection and Affordable Care Act | 2 | 2016 | 101 | 0.630 |
Why?
| | Middle Aged | 37 | 2025 | 30889 | 0.620 |
Why?
| | Respiratory Syncytial Virus Vaccines | 1 | 2018 | 34 | 0.600 |
Why?
| | Family Practice | 10 | 2017 | 455 | 0.580 |
Why?
| | United States | 34 | 2025 | 13830 | 0.560 |
Why?
| | Pneumococcal Infections | 2 | 2018 | 110 | 0.560 |
Why?
| | Immunization Programs | 6 | 2020 | 212 | 0.560 |
Why?
| | Respiratory Syncytial Virus Infections | 1 | 2018 | 119 | 0.560 |
Why?
| | Practice Guidelines as Topic | 8 | 2024 | 1478 | 0.540 |
Why?
| | Clinical Competence | 3 | 2018 | 1013 | 0.520 |
Why?
| | Humans | 74 | 2025 | 128417 | 0.510 |
Why?
| | Preventive Health Services | 1 | 2016 | 145 | 0.450 |
Why?
| | Female | 44 | 2025 | 68153 | 0.440 |
Why?
| | Pediatrics | 11 | 2021 | 1046 | 0.440 |
Why?
| | Insurance, Health | 1 | 2016 | 267 | 0.430 |
Why?
| | Male | 40 | 2025 | 62857 | 0.420 |
Why?
| | Aged | 16 | 2025 | 21953 | 0.400 |
Why?
| | Meningococcal Vaccines | 3 | 2018 | 53 | 0.380 |
Why?
| | Mumps | 2 | 2022 | 24 | 0.370 |
Why?
| | Age Factors | 8 | 2021 | 3103 | 0.340 |
Why?
| | Medicare Part D | 1 | 2010 | 24 | 0.340 |
Why?
| | Health Services Research | 2 | 2018 | 391 | 0.340 |
Why?
| | Clinical Decision-Making | 3 | 2021 | 304 | 0.330 |
Why?
| | Rotavirus Vaccines | 3 | 2021 | 49 | 0.310 |
Why?
| | Nephrology | 1 | 2009 | 60 | 0.300 |
Why?
| | Neuralgia, Postherpetic | 1 | 2008 | 40 | 0.290 |
Why?
| | Minority Groups | 1 | 2010 | 251 | 0.290 |
Why?
| | Rotavirus Infections | 2 | 2021 | 45 | 0.280 |
Why?
| | Gynecology | 3 | 2019 | 175 | 0.280 |
Why?
| | Emigrants and Immigrants | 1 | 2009 | 122 | 0.270 |
Why?
| | Cross-Sectional Studies | 5 | 2025 | 5039 | 0.250 |
Why?
| | Meningococcal Infections | 2 | 2018 | 23 | 0.240 |
Why?
| | Vaccines, Conjugate | 2 | 2018 | 63 | 0.240 |
Why?
| | Pregnancy Complications, Infectious | 2 | 2020 | 364 | 0.230 |
Why?
| | Vaccination Coverage | 1 | 2025 | 79 | 0.220 |
Why?
| | Professional-Family Relations | 2 | 2016 | 144 | 0.220 |
Why?
| | Physician-Patient Relations | 3 | 2019 | 535 | 0.220 |
Why?
| | Adverse Drug Reaction Reporting Systems | 1 | 2024 | 74 | 0.220 |
Why?
| | Kidney Failure, Chronic | 1 | 2009 | 535 | 0.210 |
Why?
| | Data Mining | 1 | 2024 | 109 | 0.210 |
Why?
| | Tinnitus | 1 | 2024 | 56 | 0.210 |
Why?
| | Beclomethasone | 1 | 2022 | 27 | 0.200 |
Why?
| | Rubella | 1 | 2022 | 23 | 0.190 |
Why?
| | Neisseria meningitidis, Serogroup B | 2 | 2018 | 15 | 0.190 |
Why?
| | Measles | 1 | 2022 | 44 | 0.190 |
Why?
| | Electronic Health Records | 3 | 2025 | 974 | 0.180 |
Why?
| | Herpesvirus 3, Human | 2 | 2019 | 330 | 0.180 |
Why?
| | Refusal to Treat | 1 | 2020 | 17 | 0.180 |
Why?
| | Insurance Coverage | 3 | 2018 | 220 | 0.170 |
Why?
| | Standing Orders | 1 | 2020 | 11 | 0.170 |
Why?
| | Norovirus | 1 | 2020 | 23 | 0.170 |
Why?
| | Advisory Committees | 1 | 2021 | 218 | 0.160 |
Why?
| | Cost of Illness | 2 | 2018 | 277 | 0.160 |
Why?
| | Adolescent | 11 | 2025 | 20179 | 0.160 |
Why?
| | Policy | 1 | 2020 | 143 | 0.160 |
Why?
| | Obstetrics | 2 | 2019 | 161 | 0.160 |
Why?
| | Gastroenteritis | 1 | 2020 | 66 | 0.160 |
Why?
| | Evidence-Based Medicine | 2 | 2020 | 711 | 0.150 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2020 | 146 | 0.150 |
Why?
| | Anti-Asthmatic Agents | 1 | 2022 | 371 | 0.150 |
Why?
| | Respiratory Syncytial Virus, Human | 1 | 2018 | 68 | 0.150 |
Why?
| | Awareness | 1 | 2018 | 98 | 0.140 |
Why?
| | Cardiovascular Diseases | 1 | 2010 | 1999 | 0.140 |
Why?
| | Professional Practice | 1 | 2018 | 64 | 0.140 |
Why?
| | Glucocorticoids | 1 | 2022 | 571 | 0.140 |
Why?
| | Patients | 1 | 2018 | 166 | 0.140 |
Why?
| | Hepatitis A | 1 | 2017 | 25 | 0.140 |
Why?
| | Quality of Life | 3 | 2023 | 2680 | 0.130 |
Why?
| | Health Plan Implementation | 1 | 2018 | 136 | 0.130 |
Why?
| | Information Systems | 1 | 2016 | 62 | 0.130 |
Why?
| | Physician's Role | 2 | 2019 | 206 | 0.130 |
Why?
| | Text Messaging | 1 | 2018 | 149 | 0.130 |
Why?
| | Young Adult | 5 | 2025 | 12312 | 0.130 |
Why?
| | Self-Management | 1 | 2018 | 162 | 0.120 |
Why?
| | Directive Counseling | 1 | 2016 | 46 | 0.120 |
Why?
| | Parents | 4 | 2021 | 1304 | 0.120 |
Why?
| | Colorado | 4 | 2019 | 4375 | 0.120 |
Why?
| | Child | 13 | 2022 | 20655 | 0.120 |
Why?
| | Treatment Refusal | 1 | 2015 | 87 | 0.120 |
Why?
| | Patient Acceptance of Health Care | 3 | 2016 | 758 | 0.110 |
Why?
| | Health Care Costs | 1 | 2017 | 367 | 0.110 |
Why?
| | Medicare | 2 | 2018 | 715 | 0.110 |
Why?
| | Attitude to Health | 1 | 2017 | 431 | 0.110 |
Why?
| | Chi-Square Distribution | 2 | 2018 | 511 | 0.110 |
Why?
| | Documentation | 1 | 2015 | 181 | 0.110 |
Why?
| | Health Surveys | 2 | 2018 | 492 | 0.100 |
Why?
| | Medically Uninsured | 1 | 2014 | 127 | 0.100 |
Why?
| | Self Report | 3 | 2024 | 801 | 0.100 |
Why?
| | Interdisciplinary Communication | 1 | 2014 | 187 | 0.100 |
Why?
| | Pregnancy | 5 | 2025 | 6357 | 0.100 |
Why?
| | Neisseria meningitidis | 1 | 2011 | 22 | 0.100 |
Why?
| | Infant | 6 | 2024 | 8914 | 0.090 |
Why?
| | Administration, Inhalation | 2 | 2023 | 661 | 0.090 |
Why?
| | Safety | 1 | 2013 | 327 | 0.090 |
Why?
| | Fees, Pharmaceutical | 1 | 2010 | 10 | 0.090 |
Why?
| | Internet | 2 | 2019 | 617 | 0.080 |
Why?
| | Aged, 80 and over | 2 | 2011 | 7033 | 0.080 |
Why?
| | Data Collection | 4 | 2014 | 647 | 0.080 |
Why?
| | Hepatitis B Vaccines | 1 | 2009 | 47 | 0.080 |
Why?
| | Mexican Americans | 1 | 2010 | 113 | 0.080 |
Why?
| | Adrenal Cortex Hormones | 2 | 2023 | 518 | 0.080 |
Why?
| | Hepatitis B | 1 | 2009 | 60 | 0.080 |
Why?
| | Referral and Consultation | 1 | 2014 | 727 | 0.070 |
Why?
| | ROC Curve | 1 | 2010 | 500 | 0.070 |
Why?
| | Kaplan-Meier Estimate | 1 | 2010 | 853 | 0.070 |
Why?
| | Regression Analysis | 2 | 2020 | 978 | 0.070 |
Why?
| | Health Personnel | 3 | 2019 | 644 | 0.070 |
Why?
| | Electronic Mail | 2 | 2018 | 60 | 0.070 |
Why?
| | Costs and Cost Analysis | 2 | 2018 | 199 | 0.070 |
Why?
| | Proportional Hazards Models | 1 | 2010 | 1196 | 0.070 |
Why?
| | Kidney Diseases | 1 | 2009 | 367 | 0.060 |
Why?
| | Medicaid | 2 | 2021 | 433 | 0.060 |
Why?
| | Renal Dialysis | 1 | 2009 | 417 | 0.060 |
Why?
| | Risk Assessment | 2 | 2015 | 3232 | 0.060 |
Why?
| | Predictive Value of Tests | 1 | 2010 | 1935 | 0.060 |
Why?
| | Seasons | 2 | 2020 | 497 | 0.060 |
Why?
| | Vaccines, Combined | 1 | 2023 | 48 | 0.050 |
Why?
| | Nebulizers and Vaporizers | 1 | 2023 | 81 | 0.050 |
Why?
| | Bacterial Vaccines | 1 | 2023 | 62 | 0.050 |
Why?
| | Time Factors | 2 | 2010 | 6482 | 0.050 |
Why?
| | Bayes Theorem | 1 | 2024 | 369 | 0.050 |
Why?
| | Kidney | 1 | 2009 | 1302 | 0.050 |
Why?
| | Symptom Flare Up | 1 | 2022 | 38 | 0.050 |
Why?
| | Measles-Mumps-Rubella Vaccine | 1 | 2022 | 42 | 0.050 |
Why?
| | Incidence | 2 | 2024 | 2616 | 0.050 |
Why?
| | Delivery of Health Care | 1 | 2009 | 895 | 0.050 |
Why?
| | Mumps Vaccine | 1 | 2021 | 13 | 0.050 |
Why?
| | Risk Factors | 3 | 2010 | 9704 | 0.050 |
Why?
| | Qualitative Research | 2 | 2018 | 1226 | 0.040 |
Why?
| | Vaccines, Inactivated | 1 | 2021 | 69 | 0.040 |
Why?
| | Hypertension | 1 | 2009 | 1235 | 0.040 |
Why?
| | Vaccines, Attenuated | 1 | 2021 | 126 | 0.040 |
Why?
| | Attitude | 1 | 2021 | 249 | 0.040 |
Why?
| | Pandemics | 2 | 2021 | 1476 | 0.040 |
Why?
| | Disease Outbreaks | 1 | 2022 | 341 | 0.040 |
Why?
| | Serogroup | 1 | 2018 | 32 | 0.040 |
Why?
| | Postal Service | 1 | 2018 | 33 | 0.040 |
Why?
| | Pharmacists | 1 | 2021 | 261 | 0.040 |
Why?
| | Diphtheria | 1 | 2017 | 20 | 0.040 |
Why?
| | Tetanus | 1 | 2017 | 25 | 0.040 |
Why?
| | Research Design | 1 | 2024 | 1036 | 0.040 |
Why?
| | Whooping Cough | 1 | 2017 | 48 | 0.040 |
Why?
| | Population Groups | 1 | 2017 | 58 | 0.040 |
Why?
| | Safety-net Providers | 1 | 2018 | 108 | 0.030 |
Why?
| | Professional Practice Gaps | 1 | 2016 | 13 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2020 | 1484 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2023 | 2675 | 0.030 |
Why?
| | Equipment and Supplies | 1 | 2015 | 41 | 0.030 |
Why?
| | Focus Groups | 1 | 2017 | 452 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2021 | 2710 | 0.030 |
Why?
| | Sex Factors | 1 | 2019 | 1945 | 0.030 |
Why?
| | Communication | 1 | 2019 | 838 | 0.030 |
Why?
| | Decision Support Systems, Clinical | 1 | 2016 | 206 | 0.030 |
Why?
| | Societies, Medical | 1 | 2017 | 745 | 0.030 |
Why?
| | Circovirus | 1 | 2013 | 7 | 0.030 |
Why?
| | Life Style | 1 | 2015 | 460 | 0.030 |
Why?
| | Intussusception | 1 | 2013 | 27 | 0.030 |
Why?
| | Drug Contamination | 1 | 2013 | 50 | 0.030 |
Why?
| | Product Surveillance, Postmarketing | 1 | 2013 | 59 | 0.030 |
Why?
| | Professional Practice Location | 1 | 2011 | 29 | 0.020 |
Why?
| | Health Services Accessibility | 1 | 2019 | 896 | 0.020 |
Why?
| | Community-Institutional Relations | 1 | 2012 | 96 | 0.020 |
Why?
| | Swine | 1 | 2013 | 742 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2021 | 5687 | 0.020 |
Why?
| | Child, Preschool | 2 | 2015 | 10384 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2018 | 4892 | 0.020 |
Why?
| | Diabetes Complications | 1 | 2009 | 223 | 0.020 |
Why?
| | Vascular Diseases | 1 | 2009 | 232 | 0.020 |
Why?
| | Risk-Taking | 1 | 2009 | 347 | 0.020 |
Why?
| | Glomerular Filtration Rate | 1 | 2009 | 681 | 0.020 |
Why?
| | Logistic Models | 1 | 2009 | 1974 | 0.010 |
Why?
| | Chronic Disease | 1 | 2009 | 1705 | 0.010 |
Why?
| | Cohort Studies | 1 | 2009 | 5388 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2009 | 14454 | 0.010 |
Why?
| | Animals | 1 | 2013 | 34479 | 0.010 |
Why?
|
|
Hurley's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|